Welcome

Thank you very much for your interest in our study. We are attempting to assess the efficacy of Extended-Release Naltrexone and Extended-Release Buprenorphine vs. placebo for the treatment of Cocaine Use Disorder in adults ages 18-65. The study is conducted under Dr. Jon Grant at the University of Chicago and involves screening and baseline visits and then visits once or twice a week for approximately sixteen weeks. Depending on individual circumstances, there would be a total of 22-26 visits. Participants will be compensated for their time and travel.

The information you provide here, including the information you report about your substance use, will be kept confidential and will not be used for any purposes other than seeing if you are eligible to participate in the study.

If you have additional questions, please call 773-702-5523.

Question Title

* 1. Are you willing to participate in an approximately 16-week clinical trial where you will receive extended-release naltrexone and extended-release buprenorphine or a placebo?

Question Title

* 2. Do you understand English and can respond to questions, both verbally and written, in the language?

Question Title

* 3. Are you between 18-65 years of age?

T